John C. Lam
Impact in
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders
Papers in ⓘ
-
- Antimicrobial Resistance in Staphylococcus 6
- Amoebic Infections and Treatments 3
- Antifungal resistance and susceptibility 3
- Co-authors
- Michael D. Parkins (13 shared papers)Emiel A. M. Janssen (1 shared paper)Ronald J. A. Wanders (1 shared paper)P. G. Barth (1 shared paper)P. Vreken (1 shared paper)Frank Baas (1 shared paper)Ranjani Somayaji (7 shared papers)Taco W. Kuijpers (3 shared papers)
- Journals
- BMC Infectious Diseases (4 papers)Journal of Inherited Metabolic Disease (2 papers)AIDS Education and Prevention (1 paper)European Journal of Cancer (1 paper)Journal of Cystic Fibrosis (1 paper)
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
John C. Lam
33 papers receiving 555 citations
Peers
Comparison fields: 5 of 78
- Clinical Biochemistry 67
- Molecular Medicine 31
- Infectious Diseases 114
- Pulmonary and Respiratory Medicine 181
- Applied Microbiology and Biotechnology 10
Countries citing papers authored by John C. Lam
This map shows the geographic impact of John C. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Lam more than expected).
Fields of papers citing papers by John C. Lam
This network shows the impact of papers produced by John C. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Lam. The network helps show where John C. Lam may publish in the future.
Co-authors
The 25 scholars most cited alongside John C. Lam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 136 | |
| 2 | 2006 | 46 | |
| 3 | 2015 | 39 | |
| 4 | 2007 | 36 | |
| 5 | 2002 | 34 | |
| 6 | 1993 | 31 | |
| 7 | 2019 | 27 | |
| 8 | 2013 | 27 | |
| 9 | 1999 | 26 | |
| 10 | 2022 | 23 | |
| 11 | 2021 | 21 | |
| 12 | 2019 | 21 | |
| 13 | 1987 | 13 | |
| 14 | 2016 | 12 | |
| 15 | 2023 | 10 | |
| 16 | 2019 | 8 | |
| 17 | 2013 | 8 | |
| 18 | 1986 | 7 | |
| 19 | 1989 | 7 | |
| 20 | 2013 | 6 |
About John C. Lam
John C. Lam is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Clinical Biochemistry, Parasitology and Epidemiology, having authored 38 papers that have together received 574 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (6 papers), Infective Endocarditis Diagnosis and Management (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), Cystic Fibrosis Research Advances (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Kawasaki Disease and Coronary Complications (3 papers), Amoebic Infections and Treatments (3 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Clinical Biochemistry (67 citations), Molecular Medicine (31 citations), Infectious Diseases (114 citations), Pulmonary and Respiratory Medicine (181 citations) and Applied Microbiology and Biotechnology (10 citations). John C. Lam has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Michael D. Parkins, Emiel A. M. Janssen, Ronald J. A. Wanders, P. G. Barth, P. Vreken, Frank Baas, Ranjani Somayaji, Taco W. Kuijpers, William Stokes and Daniel B. Gregson. Their work appears in journals such as BMC Infectious Diseases, Journal of Inherited Metabolic Disease, AIDS Education and Prevention, European Journal of Cancer and Journal of Cystic Fibrosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.